Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$50.21

0.25 (0.50%)

14:17
09/29/19
09/29
14:17
09/29/19
14:17

Bristol-Myers announces efficacy data analysis from Phase 3 CheckMate -238 trial

Bristol-Myers Squibb announced results of a three-year analysis of efficacy data from the Phase 3 CheckMate -238 study evaluating adjuvant use of Opdivo 3 mg/kg versus Yervoy 10 mg/kg in patients with Stage III or Stage IV melanoma who were at high risk of recurrence following complete surgical resection. At three years of follow-up, Opdivo continues to demonstrate superior recurrence-free survival compared to Yervoy, the active control, with RFS rates of 58% and 45%, respectively. Distant-metastasis-free survival also continues to be significantly longer for Opdivo, with 36-month rates of 66% and 58%, respectively. Both RFS and DMFS benefit continue to be observed across key subgroups, including disease stages, BRAF mutation status and PD-L1 expression. No new safety data were generated as part of the 36-month analysis.

  • 31

    Oct

BMY Bristol-Myers
$50.21

0.25 (0.50%)

08/14/19
ATLE
08/14/19
UPGRADE
Target $63
ATLE
Overweight
Bristol-Myers upgraded to Overweight from Neutral at Atlantic Equities
Atlantic Equities analyst Steve Chesney upgraded Bristol-Myers Squibb to Overweight from Neutral and raised his price target for the shares to $63 from $51.
08/14/19
08/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Evercore Partners (EVR) upgraded to Neutral from Sell at Goldman Sachs with analyst Richard Ramsden saying believes that stronger U.S. large cap deal activity than he previously expected should support Evercore's revenues. 2. Sanofi (SNY) upgraded to Buy from Neutral at UBS with analyst Laura Sutcliffe saying she sees signs of a turnaround for the company and believes its pipeline can fixed ahead of patent expiration. 3. Bristol-Myers (BMY) upgraded to Overweight from Neutral at Atlantic Equities. 4. Horizon Pharma (HZNP) upgraded to Outperform from Market Perform at BMO Capital with analyst Gary Nachman citing the company's "strong" Q2 results driven by Krystexxa. 5. Ferrari (RACE) upgraded to Buy from Neutral at Goldman Sachs with analyst George Galliers citing the company's Q2 results earlier this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/19/19
MZHO
08/19/19
DOWNGRADE
MZHO
Neutral
Amgen, Celgene downgraded to Neutral on valuation at Mizuho
As previously reported, Mizuho analyst Salim Syed downgraded Amgen (AMGN) and Celgene (CELG), each to Neutral from Buy, "solely" on the stock's current trading prices nearing what the analyst views as appropriate valuations. Amgen has run up over the last week by about 10% following a "very clean Enbrel litigation win," but the stock price now gives full credit for its Enbrel IP, said Syed, who raised his price target on Amgen shares to $212 from $208. He also cut his price target on Celgene shares to $100 from $103, based on a calculation of one Bristol-Myers (BMY) share being worth $47, plus $50 cash per share and $3 for a risk-adjusted CVR valuation.
08/27/19
RBCM
08/27/19
NO CHANGE
Target $206
RBCM
Sector Perform
Amgen price target raised to $206 from $192 at RBC Capital
RBC Capital analyst Kennen MacKay raised his price target on Amgen to $206, saying that despite the "sticker shock" of its $13.4B deal for the Otezla franchise, the transaction is expected to be immediately accretive to earnings and fitting well with its existing inflammation and immunology portfolio. The analyst believes that Amgen should be able to grow revenue "majorly" over the next 3 years as it leverages Otezla potential with its legal victory on Enbrel, stating that there is a case for its multiple to re-rate higher. MacKay keeps his Sector Perform rating on Amgen shares as he awaits for its emerging pipeline to also "fill the shoes" of its maturing assets.

TODAY'S FREE FLY STORIES

EMR

Emerson

$67.21

(0.00%)

09:43
10/15/19
10/15
09:43
10/15/19
09:43
Periodicals
D.E. Shaw report calling for Emerson split coming today, CNBC reports »

D.E. Shaw has over a 1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

STLD

Steel Dynamics

$29.64

(0.00%)

, IGT

International Game

$14.02

(0.00%)

09:40
10/15/19
10/15
09:40
10/15/19
09:40
Options
Unusually active option classes on open October 15th »

Unusual total active…

STLD

Steel Dynamics

$29.64

(0.00%)

IGT

International Game

$14.02

(0.00%)

JPM

JPMorgan

$116.39

(0.00%)

UNH

UnitedHealth

$220.32

(0.00%)

GS

Goldman Sachs

$205.81

(0.00%)

NVDA

Nvidia

$186.51

(0.00%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.83

(0.00%)

C

Citi

$70.28

(0.00%)

WLL

Whiting Petroleum

$7.26

(0.00%)

SCHW

Charles Schwab

$37.74

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 17

    Oct

  • 18

    Oct

  • 27

    Oct

  • 04

    Nov

  • 06

    Nov

  • 12

    Nov

  • 20

    Nov

CPIX

Cumberland

$5.59

-0.05 (-0.89%)

09:38
10/15/19
10/15
09:38
10/15/19
09:38
Hot Stocks
Cumberland: Study shows Vibativ superiority in some bacterial pneumonia patients »

Cumberland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$67.21

0.16 (0.24%)

09:37
10/15/19
10/15
09:37
10/15/19
09:37
Periodicals
Breaking Periodicals news story on Emerson »

D.E. Shaw to call for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

IAC

IAC

$226.69

-0.5 (-0.22%)

, MTCH

Match Group

$74.00

-0.12 (-0.16%)

09:34
10/15/19
10/15
09:34
10/15/19
09:34
Conference/Events
Cowen US internet/media analyst to hold analyst/industry conference call »

U.S. Internet & Media…

IAC

IAC

$226.69

-0.5 (-0.22%)

MTCH

Match Group

$74.00

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.28

-0.14 (-3.17%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Encana rating change  »

Encana downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

WLL

Whiting Petroleum

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

OAS

Oasis Petroleum

$3.11

-0.135 (-4.17%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$20.44

-0.15 (-0.73%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Upgrade
Noble Energy rating change  »

Noble Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PH

Parker-Hannifin

$178.45

-1.25 (-0.70%)

09:30
10/15/19
10/15
09:30
10/15/19
09:30
Recommendations
Parker-Hannifin analyst commentary  »

Parker-Hannifin sales,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

WHD

Cactus

$28.03

-0.49 (-1.72%)

, HAL

Halliburton

$18.75

-0.195 (-1.03%)

09:30
10/15/19
10/15
09:30
10/15/19
09:30
Recommendations
Cactus, Halliburton, National Oilwell, Newpark Resources, Nine Energy Services, Oil States, Patterson-UTI, Unit Corp., USA Compression analyst commentary  »

Raymond James sees…

WHD

Cactus

$28.03

-0.49 (-1.72%)

HAL

Halliburton

$18.75

-0.195 (-1.03%)

NOV

National Oilwell

$21.10

-0.08 (-0.38%)

NR

Newpark Resources

$6.93

-0.655 (-8.64%)

NINE

Nine Energy Services

$5.16

-0.24 (-4.44%)

OIS

Oil States

$12.93

-0.065 (-0.50%)

PTEN

Patterson-UTI

$8.15

-0.1 (-1.21%)

UNT

Unit Corp.

$2.83

-0.165 (-5.52%)

USAC

USA Compression

$17.40

0.225 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 29

    Oct

  • 31

    Oct

  • 11

    Nov

  • 13

    Nov

JNJ

Johnson & Johnson

$130.67

-0.68 (-0.52%)

09:28
10/15/19
10/15
09:28
10/15/19
09:28
Hot Stocks
Johnson & Johnson says will continue to consider 'opportunistic acquisitions' »

Says: Q3 was a good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

IMO

Imperial Oil

$24.25

-0.235 (-0.96%)

09:27
10/15/19
10/15
09:27
10/15/19
09:27
Upgrade
Imperial Oil rating change  »

Imperial Oil upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDFC

WD-40

$181.18

-2.86 (-1.55%)

09:26
10/15/19
10/15
09:26
10/15/19
09:26
Recommendations
WD-40 analyst commentary  »

WD-40 sets up favorably…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NMIH

NMI Holdings

$26.95

0.01 (0.04%)

09:26
10/15/19
10/15
09:26
10/15/19
09:26
Upgrade
NMI Holdings rating change  »

B. Riley FBR upgrades NMI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KSU

Kansas City Southern

$132.02

-1.5 (-1.12%)

, SAIA

Saia

$96.04

0.48 (0.50%)

09:26
10/15/19
10/15
09:26
10/15/19
09:26
Recommendations
Kansas City Southern, Saia, Union Pacific analyst commentary  »

Truck pricing, volume…

KSU

Kansas City Southern

$132.02

-1.5 (-1.12%)

SAIA

Saia

$96.04

0.48 (0.50%)

UNP

Union Pacific

$159.55

-1.82 (-1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 30

    Oct

  • 13

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

PSTV

Plus Therapeutics

$2.47

0.15 (6.47%)

09:24
10/15/19
10/15
09:24
10/15/19
09:24
Hot Stocks
Plus Therapeutics receives $4.6M reimbursement payment »

Plus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$36.05

-0.065 (-0.18%)

09:23
10/15/19
10/15
09:23
10/15/19
09:23
Earnings
Breaking Earnings news story on Knight-Swift »

Knight-Swift sees Q1 adj.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GNUS

Genius Brands

$0.83

0.0597 (7.75%)

, BABA

Alibaba

$171.22

-1.745 (-1.01%)

09:23
10/15/19
10/15
09:23
10/15/19
09:23
Hot Stocks
Genius Brands CEO says 'more bullish than ever' on future of the company »

Genius Brands…

GNUS

Genius Brands

$0.83

0.0597 (7.75%)

BABA

Alibaba

$171.22

-1.745 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KNX

Knight-Swift

$36.05

-0.065 (-0.18%)

09:23
10/15/19
10/15
09:23
10/15/19
09:23
Earnings
Knight-Swift cuts Q4 adj. EPS view to 62c-65c from 73c-77c, consensus 71c »

The updates to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

FDX

FedEx

$146.81

1.29 (0.89%)

09:22
10/15/19
10/15
09:22
10/15/19
09:22
Hot Stocks
FedEx announces expansion of FedEx Freight Direct »

FedEx Freight, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 17

    Dec

KNX

Knight-Swift

$36.05

-0.065 (-0.18%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20
Earnings
Breaking Earnings news story on Knight-Swift »

Knight-Swift cuts Q3 adj.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$119.05

-2.55 (-2.10%)

, AAPL

Apple

$235.87

-0.34 (-0.14%)

09:20
10/15/19
10/15
09:20
10/15/19
09:20
Hot Stocks
Apple TV app, Apple TV+ coming to Roku platform »

Roku (ROKU) announced the…

ROKU

Roku

$119.05

-2.55 (-2.10%)

AAPL

Apple

$235.87

-0.34 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Nov

ABEO

Abeona Therapeutics

$2.18

-0.05 (-2.24%)

09:19
10/15/19
10/15
09:19
10/15/19
09:19
Hot Stocks
Abeona announces publication of long-term data from Phase 1/2a trial of EB-101 »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.